Gonococcal antimicrobial susceptibility surveillance in Europe, 2016

Surveillance report
Publication series: Gonococcal antimicrobial susceptibility surveillance in Europe
Cite:
Citation Link

European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in Europe, 2016. Stockholm: ECDC; 2018

Copy citation to clipboard

The overall aim of Euro-GASP is to strengthen the surveillance of gonococcal antimicrobial susceptibility in EU/EEA Member States in order to provide quality-assured data to inform gonorrhoea treatment guidelines. This report presents the results from the 2016 gonococcal antimicrobial susceptibility sentinel surveillance.

Read more

Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Related updates on Neisseria gonorrhoeae

Publication

Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe

Technical report -

Publication

Communicable disease threats report, 8-14 September 2019, week 37

Publication -

Publication

Developing a national strategy for the prevention and control of sexually transmitted infections

Technical report -

Publication

Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing

External quality assessment -

Data

Presentation: Annual Epidemiological Report for 2017: Sexually Transmitted Diseases

Graph, Map, Presentation -